These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


267 related items for PubMed ID: 23981336

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
    Li X, Vogt FG, Hayes D, Mansour HM.
    Eur J Pharm Sci; 2014 Feb 14; 52():191-205. PubMed ID: 24215736
    [Abstract] [Full Text] [Related]

  • 5. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin.
    Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Nokhodchi A.
    Int J Pharm; 2010 Apr 15; 389(1-2):74-85. PubMed ID: 20085803
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate.
    Simon A, Amaro MI, Cabral LM, Healy AM, de Sousa VP.
    Int J Pharm; 2016 Mar 30; 501(1-2):124-38. PubMed ID: 26836711
    [Abstract] [Full Text] [Related]

  • 13. Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles.
    Keil TWM, Feldmann DP, Costabile G, Zhong Q, da Rocha S, Merkel OM.
    Eur J Pharm Biopharm; 2019 Oct 30; 143():61-69. PubMed ID: 31445157
    [Abstract] [Full Text] [Related]

  • 14. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW, Li X, Vogt FG, Hayes D, Zwischenberger JB, Park ES, Mansour HM.
    Int J Pharm; 2013 Oct 15; 455(1-2):374-92. PubMed ID: 23820131
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Stabilization of IgG1 in spray-dried powders for inhalation.
    Schüle S, Schulz-Fademrecht T, Garidel P, Bechtold-Peters K, Frieb W.
    Eur J Pharm Biopharm; 2008 Aug 15; 69(3):793-807. PubMed ID: 18477504
    [Abstract] [Full Text] [Related]

  • 19. A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibiotics.
    Chan JG, Chan HK, Prestidge CA, Denman JA, Young PM, Traini D.
    Eur J Pharm Biopharm; 2013 Feb 15; 83(2):285-92. PubMed ID: 22982733
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.